Lower urinary tract symptom prevalence and management among patients with multiple sclerosis

International Journal of MS Care
Kristin M KhalafJack Burks

Abstract

This study was conducted to assess self-reported prevalence and management of lower urinary tract symptoms (LUTS), along with drivers of treatment seeking, among patients with multiple sclerosis (MS). An online, cross-sectional survey was administered to US-residing participants with self-reported MS to assess presence of LUTS, including urinary incontinence (UI). Participants experiencing LUTS were asked additional questions related to management and current therapies. Multivariate logistic regression identified drivers of treatment-seeking behavior. A total of 1052 participants completed the survey; 1047 were included in the analysis. Nine hundred sixty-six participants (92%) reported at least one LUTS, the most common being post-micturition dribble (64.9%), urinary urgency (61.7%), and a feeling of incomplete emptying (60.7%). Eight hundred twenty-six (79%) reported having some type of UI. Of those with any type of LUTS, 70% (n = 680) had previously discussed urinary symptoms with a health-care provider (HCP), while only 32% (n = 311) had seen an HCP in the past year. Logistic regression found urgency (odds ratio [OR] 1.20 [95% confidence interval (CI), 1.00-1.44]), intermittent urine stream (OR 1.40 [95% CI, 1.15-1.69]), an...Continue Reading

References

May 1, 1990·Obstetrics and Gynecology·I NygaardE Murphy
Feb 1, 1994·Journal of the American Geriatrics Society·K L BurgioL H Kuller
May 27, 1999·PharmacoEconomics·R M O'ConorG Kobelt-Nguyen
Oct 12, 1999·Multiple Sclerosis : Clinical and Laboratory Research·M J HoholH L Weiner
Feb 22, 2002·Neurourology and Urodynamics·Paul AbramsUNKNOWN Standardisation Sub-committee of the International Continence Society
Sep 10, 2002·Human Molecular Genetics·Jonathan L HainesUNKNOWN Multiple Sclerosis Genetics Group
Sep 16, 2004·QJM : Monthly Journal of the Association of Physicians·L HemmettN Russell
Apr 13, 2005·International Urogynecology Journal and Pelvic Floor Dysfunction·Linda Brubaker, Bob Shull
May 16, 2006·International Urogynecology Journal and Pelvic Floor Dysfunction·Giuseppe QuartoRocco Damiano
Oct 21, 2006·Lancet Neurology·Sarah-Michelle OrtonUNKNOWN Canadian Collaborative Study Group
Feb 14, 2007·Multiple Sclerosis : Clinical and Laboratory Research·M W NortvedtK M Myhr
Mar 11, 2009·Expert Review of Neurotherapeutics·Pamela A McCombeMichael W Jackson
Sep 14, 2010·Multiple Sclerosis : Clinical and Laboratory Research·Enrico MillefioriniValentina Durastanti

❮ Previous
Next ❯

Citations

Jul 28, 2015·International Journal of Molecular Sciences·Alexandra PintérTimo Siepmann
Apr 8, 2015·Neurourology and Urodynamics·Emmanuel Chartier-KastlerMichael Chancellor
May 31, 2015·Current Urology Reports·Areeba Sadiq, Benjamin M Brucker
Feb 18, 2017·Current Opinion in Urology·Petros Georgopoulos, Apostolos Apostolidis
Dec 9, 2017·International Journal of Older People Nursing·Joan Ostaszkiewicz
May 3, 2016·F1000Research·Arman A Kahokehr, Peter J Gilling
May 7, 2020·Neurodegenerative Disease Management·Galina VorobeychikAshley Cox
May 27, 2020·Expert Opinion on Pharmacotherapy·Aurora ZanghìEmanuele D'Amico
May 16, 2020·International Journal of MS Care·Hawra B Al DandanDoreen McClurg
Nov 17, 2016·Investigative and Clinical Urology·James M Tracey, John T Stoffel
Apr 9, 2020·Annals of Physical and Rehabilitation Medicine·Thomas F MonaghanAlan J Wein
Jun 21, 2020·Multiple Sclerosis and Related Disorders·Burkhard DomurathUNKNOWN MS Consensus Group

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.